See more : Igis Neptune Barcelona Holdco Socimi, S.A. (MLABC.PA) Income Statement Analysis – Financial Results
Complete financial analysis of By-health Co., Ltd. (300146.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of By-health Co., Ltd., a leading company in the Packaged Foods industry within the Consumer Defensive sector.
- AstraZeneca Pharma India Limited (ASTRAZEN.NS) Income Statement Analysis – Financial Results
- TMK Energy Limited (TMK.AX) Income Statement Analysis – Financial Results
- Verra Mobility Corporation (VRRMW) Income Statement Analysis – Financial Results
- Tips Industries Limited (TIPSINDLTD.BO) Income Statement Analysis – Financial Results
- Eloxx Pharmaceuticals, Inc. (ELOX) Income Statement Analysis – Financial Results
By-health Co., Ltd. (300146.SZ)
About By-health Co., Ltd.
By-health Co., Ltd. produces and sells dietary supplements worldwide. The company offers proteins and vitamins/minerals; and various products for skeleton and joints, heart and cerebral vessels, beauty maintenance, immunity boosting, weight management, vigor enhancement, eye nutrition, sleep improvement, blood glucose management, memory improvement, reproductive health, childhood nutrition, and pregnant women nutrition, as well as for liver, intestines, and stomach. It provides its products for children, men, women, and elderly people under the By-health and GymMax brand names through distributors, retail terminals, and online channels. The company was formerly known as Guangdong By-Health Biotechnology Co., Ltd. and changed its name to By-health Co., Ltd. in April 2012. By-health Co., Ltd. was founded in 1995 and is headquartered in Guangzhou, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9.41B | 7.86B | 7.43B | 6.09B | 5.26B | 4.35B | 3.11B | 2.31B | 2.27B | 1.70B | 1.48B | 1.07B | 657.96M | 346.08M | 205.29M | 141.86M | 66.85M |
| Cost of Revenue | 2.93B | 2.49B | 2.52B | 2.27B | 1.80B | 1.41B | 1.02B | 822.07M | 764.21M | 580.01M | 523.27M | 390.70M | 235.82M | 122.97M | 75.53M | 56.33M | 30.79M |
| Gross Profit | 6.48B | 5.37B | 4.91B | 3.83B | 3.46B | 2.94B | 2.09B | 1.49B | 1.50B | 1.12B | 958.97M | 675.99M | 422.14M | 223.11M | 129.76M | 85.53M | 36.06M |
| Gross Profit Ratio | 68.89% | 68.28% | 66.06% | 62.82% | 65.78% | 67.66% | 67.08% | 64.40% | 66.28% | 65.98% | 64.70% | 63.37% | 64.16% | 64.47% | 63.21% | 60.29% | 53.94% |
| Research & Development | 169.37M | 158.50M | 150.30M | 139.95M | 126.04M | 103.49M | 77.26M | 95.84M | 86.04M | 52.80M | 44.23M | 19.76M | 6.81M | 2.54M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 132.41M | 68.96M | 81.44M | 109.60M | 110.99M | 123.44M | 83.17M | 45.46M | 29.81M | 46.02M | 41.52M | 24.34M | 18.69M | 10.50M | 20.23M | 18.10M | 8.03M |
| Selling & Marketing | 3.22B | 3.17B | 2.48B | 1.82B | 1.65B | 1.28B | 973.27M | 638.85M | 618.61M | 397.04M | 317.02M | 265.89M | 180.85M | 85.79M | 45.80M | 29.76M | 10.83M |
| SG&A | 4.21B | 3.24B | 2.56B | 1.93B | 1.76B | 1.40B | 1.06B | 684.31M | 648.42M | 443.06M | 358.53M | 290.23M | 199.54M | 96.29M | 66.04M | 47.86M | 18.86M |
| Other Expenses | 775.42K | 374.01M | 346.36M | 386.44M | 320.08M | 26.39M | 6.64M | 25.01M | 19.66M | 39.10M | 5.63M | 3.16M | 2.60M | 460.82K | 372.16K | -399.62K | -162.33K |
| Operating Expenses | 4.41B | 3.77B | 3.06B | 2.45B | 2.21B | 1.75B | 1.29B | 884.77M | 839.28M | 577.89M | 473.80M | 366.99M | 239.58M | 116.76M | 68.10M | 49.12M | 18.96M |
| Cost & Expenses | 7.34B | 6.26B | 5.58B | 4.72B | 4.01B | 3.16B | 2.31B | 1.71B | 1.60B | 1.16B | 997.08M | 757.69M | 475.40M | 239.73M | 143.63M | 105.44M | 49.75M |
| Interest Income | 65.53M | 41.21M | 47.44M | 18.08M | 40.89M | 43.55M | 53.01M | 48.14M | 52.48M | 44.47M | 34.83M | 36.67M | 36.91M | 2.30M | 71.53K | 44.46K | 32.81K |
| Interest Expense | 4.71M | 2.20M | 10.18M | 23.73M | 44.50M | 17.59M | 274.38K | 7.35M | 51.25M | 385.29K | 423.36K | 567.39K | 198.33K | 617.02K | 182.18K | 81.21K | 9.12K |
| Depreciation & Amortization | 244.43M | 240.19M | 241.49M | 205.92M | 245.24M | 149.18M | 105.48M | 91.33M | 60.03M | 43.56M | 36.63M | 21.68M | 7.35M | 4.41M | 2.43M | 927.93K | 475.19K |
| EBITDA | 2.49B | 1.96B | 2.42B | 2.00B | -120.40M | 1.31B | 995.86M | 764.41M | 747.88M | 590.64M | 521.80M | 355.97M | 227.47M | 112.93M | 63.96M | 35.47M | 18.92M |
| EBITDA Ratio | 26.45% | 27.55% | 32.43% | 28.74% | 30.32% | 33.33% | 34.59% | 34.54% | 33.00% | 36.86% | 36.69% | 34.63% | 34.82% | 32.75% | 31.33% | 25.11% | 28.31% |
| Operating Income | 2.07B | 1.61B | 2.03B | 1.79B | 1.35B | 1.10B | 878.36M | 635.83M | 720.83M | 554.11M | 502.79M | 331.73M | 217.42M | 107.45M | 61.37M | 34.95M | 17.87M |
| Operating Income Ratio | 21.99% | 20.47% | 27.27% | 29.35% | 25.59% | 25.34% | 28.24% | 27.54% | 31.81% | 32.50% | 33.92% | 31.10% | 33.04% | 31.05% | 29.89% | 24.64% | 26.73% |
| Total Other Income/Expenses | 127.33M | 106.29M | 151.22M | -20.03M | -1.77B | 26.39M | 11.74M | 17.89M | 19.13M | 38.13M | 34.80M | -524.18K | 2.50M | 447.60K | -12.99K | -484.46K | -2.19M |
| Income Before Tax | 2.20B | 1.70B | 2.18B | 1.77B | -424.87M | 1.13B | 885.00M | 653.72M | 739.96M | 592.24M | 503.21M | 331.20M | 219.93M | 107.90M | 61.35M | 34.46M | 15.68M |
| Income Before Tax Ratio | 23.34% | 21.69% | 29.31% | 29.02% | -8.07% | 25.95% | 28.45% | 28.31% | 32.65% | 34.74% | 33.95% | 31.05% | 33.43% | 31.18% | 29.89% | 24.30% | 23.46% |
| Income Tax Expense | 417.18M | 293.53M | 411.70M | 224.59M | -9.82M | 220.56M | 118.20M | 146.06M | 119.62M | 89.64M | 81.52M | 50.85M | 33.49M | 15.80M | 9.18M | 7.76M | 3.55M |
| Net Income | 1.75B | 1.39B | 1.75B | 1.52B | -415.05M | 1.00B | 766.26M | 535.21M | 635.50M | 502.59M | 421.69M | 280.35M | 186.44M | 92.11M | 52.17M | 26.71M | 12.13M |
| Net Income Ratio | 18.56% | 17.63% | 23.60% | 25.01% | -7.89% | 23.03% | 24.63% | 23.18% | 28.04% | 29.48% | 28.45% | 26.28% | 28.34% | 26.61% | 25.41% | 18.83% | 18.14% |
| EPS | 1.03 | 0.82 | 1.03 | 0.96 | -0.28 | 0.69 | 0.52 | 0.37 | 0.44 | 0.39 | 0.32 | 0.21 | 0.14 | 0.09 | 0.06 | 0.04 | 0.39 |
| EPS Diluted | 1.03 | 0.82 | 1.03 | 0.96 | -0.28 | 0.69 | 0.52 | 0.37 | 0.44 | 0.38 | 0.32 | 0.21 | 0.14 | 0.09 | 0.06 | 0.04 | 0.39 |
| Weighted Avg Shares Out | 1.70B | 1.70B | 1.70B | 1.58B | 1.48B | 1.45B | 1.46B | 1.45B | 1.44B | 1.31B | 1.32B | 1.32B | 1.32B | 986.85M | 863.54M | 720.13M | 31.19M |
| Weighted Avg Shares Out (Dil) | 1.70B | 1.70B | 1.70B | 1.58B | 1.48B | 1.45B | 1.47B | 1.45B | 1.44B | 1.32B | 1.32B | 1.32B | 1.32B | 986.85M | 863.54M | 720.13M | 31.19M |
Source: https://incomestatements.info
Category: Stock Reports